Pricing Log in Create free account

Entera Bio Ltd. (ENTX) vs Puma Biotechnology, Inc. (PBYI)

Entera Bio Ltd. and Puma Biotechnology, Inc. are both Biotechnology companies. Entera Bio Ltd. and Puma Biotechnology, Inc. are of similar size ($530.5M and $527.6M). Entera Bio Ltd. has negative trailing earnings, so its P/E is not meaningful; Puma Biotechnology, Inc. trades at 18.9×. Entera Bio Ltd. grew revenue faster over the last twelve months: 66.4% against −2.86%. Puma Biotechnology, Inc. has the higher net margin (11.6% vs 0.00%) and the higher return on invested capital (42.6% vs 0.00%). Across the 17 metrics below, Puma Biotechnology, Inc. leads on 14 and Entera Bio Ltd. on 3.

Valuation

Metric ENTX PBYI Biotechnology median
P/E n/m 18.94 10.64
P/S 694.55 2.25 9.59
P/B 21.32 3.76 2.15
Price to free cash flow n/m 18.24 26.07
EV/EBITDA n/m 10.98 0.65
EV/Sales 629.36 1.94 9.45
Earnings yield (11.40%) 5.28% (34.69%)
Free cash flow yield (7.10%) 5.48% (24.02%)

Profitability

Metric ENTX PBYI Biotechnology median
Gross margin 0.00% 74.83% 65.59%
Operating margin 0.00% 13.16% 0.00%
Net margin 0.00% 11.55% 0.00%
Free cash flow margin 0.00% 17.79% 0.00%
Return on equity (138.92%) 21.97% (51.96%)
Return on assets (87.02%) 13.78% (46.06%)
Return on invested capital 0.00% 42.61% 0.00%

Growth

Metric ENTX PBYI Biotechnology median
Revenue growth (TTM) 66.42% (2.86%) 4.59%
EPS growth (last fiscal year) 0.00% (1.61%) 29.88%
Revenue growth, 5-year CAGR (29.19%) 0.29% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ENTX PBYI Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 8.98 2.91 4.86
Net debt to EBITDA 1.29 (1.60) 1.01

Dividend

Metric ENTX PBYI Biotechnology median
Dividend yield — — 0.38%
Payout ratio — — —

Size

Metric ENTX PBYI Biotechnology median
Market cap 530.46m 527.55m 174.29m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack